Barry Sharpe, DO
Orthopaedic Surgery · Newark, DENPI 1972965671
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Episurf Medical, Inc. at 38.7% of the total. 2025 is the largest year on record at $17,007, 7.5 times the $2,281 reported in 2019.
Across 115 payments — averaging $228.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Episurf Medical, Inc.$10K
- Arthrex$4K
- CDC Medical LLC$3K
- Stryker$3K
- Synthes USA Products LLC$3K
- Forma Medical$1K
- plus $2K from 10 others
What the payments were for
- Consulting fees$13,95253%
- Travel & lodging$2,78111%
- Food & beverage$4,95819%
- Education$4,58317%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Episurf Medical, Inc. | 2 | $10,175 |
| Arthrex | 29 | $3,938 |
| CDC Medical LLC | 2 | $3,481 |
| Stryker | 55 | $3,176 |
| Synthes USA Products LLC | 3 | $2,513 |
| Forma Medical | 2 | $1,024 |
| Eclipse Technology Solutions Inc. | 10 | $702 |
| Medical Device Business Services, Inc. | 1 | $490 |
| Exactech, Inc. | 2 | $190 |
| Curonix LLC | 1 | $138 |
| Acuitive Technologies, Inc | 1 | $114 |
| Johnson & Johnson(2 entities) | 3 | $104 |
| Medshape, Inc. | 1 | $75 |
| Smith+Nephew | 1 | $74 |
| Zimmer Biomet | 1 | $59 |
| Vertex | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OptimalMTP$975
- INFINITY$878
- INFINITY ADAPTIS$420
- STAR$274
- INBONE$212
- AUGMENT INJECTABLE$162
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$138
- CITREFIX$137
- DISTAL EXTREMITIES INSTRUMENTS TRAUMA UPPER EXTREMITY TRAUMA$124
How this compares
$26,274 in reported general payments places this provider in the 80th percentile of 70 orthopaedic surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 58 | $308 |
| Oxycodone Hcl | 65 | $248 |
| Celecoxib | 13 | $244 |
| Ondansetron OdtOndansetron | 36 | $241 |
| Methylprednisolone | 39 | $225 |
| Meloxicam | 41 | $181 |
| Ketorolac Tromethamine | 23 | $180 |
| Tramadol Hcl | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Newark
- Jeremie AxeNewark$179K
- Kenneth LingenfelterNewark$67K
- Drew BradyNewark$64K
- Samuel MeaseNewark$16K
- Adam SantoroNewark$9K
- Elliott LeitmanNewark$4K
- James CostanzoNewark$3K
- Matthew HandlingNewark$3K
- Christopher CasscellsNewark$1K
- Michael PushkarewiczNewark$342
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.